Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.
Bank of America Merrill Lynch and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.
